Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

A more detailed review of data by the FDA showed that GLP-1 drugs do not increase the risk of suicidal ideation or behavior.

So I wasn’t surprised when Williams was hit with a whole lot of “how dare you”—as Oprah Winfrey put it on the January 13 ...

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...

Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for ...

The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...

Learn how to prevent muscle loss while taking GLP-1 medications, with expert tips on protein intake, strength training, and ...

Serena Williams opened up about her controversial decision to use GLP-1 medication for weight loss on “The Oprah Podcast.” ...

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...